A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients von FLECHNER, S. M, AVERY, R. K, FISHER, R, MASTROIANNI, B. A, PAPAJCIK, D. A, O'MALLEY, K. J, GOORMASTIC, M, GOLDFARB, D. A, MODLIN, C. S, NOVICK, A. C

Volltext

A randomized prospective trial of low-dose OKT3 induction therapy to prevent rejection and minimize side effects in recipients of kidney transplants von FLECHNER, S. M, GOLDFARB, D. A, FAIRCHILD, R, MODLIN, C. S, FISHER, R, MASTROIANNI, B, BOPARAI, N, O'MALLEY, K. J, COOK, D. J, NOVICK, A. C

Volltext

A RANDOMIZED PROSPECTIVE TRIAL OF LOW-DOSE OKT3 INDUCTION THERAPY TO PREVENT REJECTION AND MINIMIZE SIDE EFFECTS IN RECIPIENTS OF KIDNEY TRANSPLANTS1 von Flechner, Stuart M., Goldfarb, David A., Fairchild, Robert, Modlin, Charles S., Fisher, Rosemaree, Mastroianni, Barbara, Boparai, Navdeep, O???Malley, Kiaran J., Cook, Daniel J., Novick, Andrew C.

Volltext

A RANDOMIZED PROSPECTIVE TRIAL OF OKT3 VS. BASILIXIMAB FOR INDUCTION THERAPY IN RENAL TRANSPLANTATION: Abstract# 169 Poster Board #-Session: P16-I von Flechner, Stuart M., Goldfarb, David A., Fairchild, Robert, Cook, Daniel, Mastroianni, Barbara, Fisher, Rosemaree, Modlin, Charles, Gill, Indiber, Novick, Andrew C.

Volltext

A RANDOMIZED PROSPECTIVE CONTROLLED TRIAL OF ORAL ACYCLOVIR VERSUS ORAL GANCICLOVIR FOR CYTOMEGALOVIRUS PROPHYLAXIS IN HIGH-RISK KIDNEY TRANSPLANT RECIPIENTS1 von Flechner, Stuart M., Avery, Robin K., Fisher, Rosemaree, Mastroianni, Barbara A., Papajcik, Doreen A., O'Malley, Kiaran J., Goormastic, Marlene, Goldfarb, David A., Modlin, Charles S., Novick, Andrew C.

Volltext